Mechanisms by which cocoa flavanols improve metabolic syndrome and related disorders

Journal of Nutritional Biochemistry

Volumn 35, Issue , 2016, Pages 1-21

  Strat, Karen M ^a   Rowley, Thomas J ^b   Smithson, Andrew T ^a   Tessem, Jeffery S ^b   Hulver, Matthew W ^a   Liu, Dongmin ^a   Davy, Brenda M ^a   Davy, Kevin P ^a   Neilson, Andrew P ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Diabetes; Endotoxin; Epicatechin; GLP 1; Procyanidins; Cells

Indexed keywords

AGENTS AFFECTING METABOLISM; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; DIPEPTIDYL PEPTIDASE IV; ENDOTOXIN; FLAVANOL DERIVATIVE; GLUCOSE TRANSPORTER; IMMUNOMODULATING AGENT; INCRETIN; INSULIN; TIGHT JUNCTION PROTEIN; FLAVONOL DERIVATIVE;

ANIMAL EXPERIMENT; CACAO; CARBOHYDRATE METABOLISM; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG STRUCTURE; ENDOTOXEMIA; ENZYME INHIBITION; GLUCOSE HOMEOSTASIS; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; INFLAMMATION; INTESTINE FLORA; MEAL; METABOLIC SYNDROME X; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNAL TRANSDUCTION; ANALYSIS; ANIMAL; CHEMISTRY; CHOCOLATE; COLON; DIET THERAPY; DIETARY SUPPLEMENT; DYSBIOSIS; EVIDENCE BASED MEDICINE; FUNCTIONAL FOOD; GLUCOSE INTOLERANCE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLANT SEED; SEVERITY OF ILLNESS INDEX;

ANIMALS; ANTIOXIDANTS; CACAO; CHOCOLATE; COLON; DIETARY SUPPLEMENTS; DYSBIOSIS; EVIDENCE-BASED MEDICINE; FLAVONOLS; FUNCTIONAL FOOD; GASTROINTESTINAL MICROBIOME; GLUCOSE INTOLERANCE; HUMANS; INTESTINAL MUCOSA; METABOLIC SYNDROME X; SEEDS; SEVERITY OF ILLNESS INDEX;

EID: 84959330876     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.12.008     Document Type: Review

References (244)

1. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
2. Grundy S.M., Hansen B., Smith S.C., Cleeman J.I., Kahn R.A. Clinical management of metabolic syndrome: report of the American heart association/national heart, lung, and blood institute/American diabetes association conference on scientific issues related to management. Circulation 2004, 109:551-556.
3. Osakabe N., Hoshi J., Kudo N., Shibata M. The flavan-3-ol fraction of cocoa powder suppressed changes associated with early-stage metabolic syndrome in high-fat diet-fed rats. Life Sci 2014, 114:51-56.
4. Ogden C.L., Carroll M.D., Kit B.K., Flegal K.M. PRevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014, 311:806-814.
5. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014, 103:137-149.
6. Aguilar M., Bhuket T., Torres S., Liu B., Wong R.J. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 2015, 313:1973-1974.
7. Lee K.W., Kim Y.J., Lee H.J., Lee C.Y. Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem 2003, 51:7292-7295.
8. Beecher G.R. Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 2003, 133:3248S-32454.
9. Ou K.Q., Gu L.W. Absorption and metabolism of proanthocyanidins. J Funct Foods 2014, 7:43-53.
10. Gu L.W., Kelm M.A., Hammerstone J.F., Beecher G., Holden J., Haytowitz D., et al. Screening of foods containing proanthocyanidins and their structural characterization using LC-MS/MS and thiolytic degradation. J Agric Food Chem 2003, 51:7513-7521.
11. Thilakarathna S.H., Rupasinghe H.P. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 2013, 5:3367-3387.
12. Lau-Cam C.A. The absorption, metabolism, and pharmacokinetics of chocolate polyphenols. Chocolate in health and nutrition: springer science + business media 2013, 201-246. W. RR (Ed.).
13. Neilson A.P., Ferruzzi M.G. Bioavailability and metabolism of bioactive compounds from foods. Nutrition on the prevention and treatment of disease 2013, 407-423. Elsevier, Inc. 3 ed. C. AM, B. CJ, F. MG (Eds.).
14. Crozier S.J., Preston A.G., Hurst J.W., Payne M.J., Mann J., Hainly L., et al. Cacao seeds are a "super fruit": a comparative analysis of various fruit powders and products. Chem Cent J 2011, 5:5.
15. Ortega N., Reguant J., Romero M.P., Macia A., Motilva M.J. Effect of fat content on the digestibility and bioaccessibility of cocoa polyphenol by an in vitro digestion model. J Agric Food Chem 2009, 57:5743-5749.
16. Andujar I., Recio M.C., Giner R.M., Rios J.L. Cocoa polyphenols and their potential benefits for human health. Oxid Med Cell Longev 2012, 2012:906252.
17. Dorenkott M.R., Griffin L.E., Goodrich K.M., Thompson-Witrick K.A., Fundaro G., Ye L., et al. Oligomeric cocoa procyanidins possess enhanced bioactivity compared to monomeric and polymeric cocoa procyanidins for preventing the development of obesity, insulin resistance, and impaired glucose tolerance during high-fat feeding. J Agric Food Chem 2014, 62:2216-2227.
18. Goodrich K.M., Dorenkott M.R., Ye L., O'Keefe S.F., Hulver M.W., Neilson A.P. Dietary supplementation with cocoa flavanols does not alter colon tissue profiles of native flavanols and their microbial metabolites established during habitual dietary exposure in C57BL/6 J mice. J Agric Food Chem 2014, 62:11190-11199.
19. Zierath J.R., He L., Guma A., Wahlstrom E.O., Klip A., WallbergHenriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 1996, 39:1180-1189.
20. Liu K., Zhou R., Wang B., Chen K., Shi L.-Y., Zhu J.-D., et al. Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr 2013, 98:340-348.
21. Sae-tan S., Grove K.A., Lambert J.D. Weight control and prevention of metabolic syndrome by green tea. Pharmacol Res 2011, 64:146-154.
22. Rains T.M., Agarwal S., Maki K.C. Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 2011, 22:1-7.
23. Kennedy J.W., Hirshman M.F., Gervino E.V., Ocel J.V., Forse R.A., Hoenig S.J., et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999, 48:1192-1197.
24. Sanbongi C., Suzuki N., Sakane T. Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell Immunol 1997, 177:129-136.
25. Grassi D., Desideri G., Mai F., Martella L., De Feo M., Soddu D., et al. Cocoa, glucose tolerance, and insulin signaling: cardiometabolic protection. J Agric Food Chem 2015.
26. Neilson A.P., Ferruzzi M.G. Influence of formulation and processing on absorption and metabolism of flavan-3-ols from tea and cocoa. Annu Rev Food Sci Technol 2011, 2:125-151.
27. Spencer J.P., Chaudry F., Pannala A.S., Srai S.K., Debnam E., Rice-Evans C. Decomposition of cocoa procyanidins in the gastric milieu. Biochem Biophys Res Commun 2000, 272:236-241.
28. Rios L.Y., Bennett R.N., Lazarus S.A., Remesy C., Scalbert A., Williamson G. Cocoa procyanidins are stable during gastric transit in humans. Am J Clin Nutr 2002, 76:1106-1110.
29. Serra A., Macià A., Romero M.-P., Valls J., Bladé C., Arola L., et al. Bioavailability of procyanidin dimers and trimers and matrix food effects in in vitro and in vivo models. Br J Nutr 2010, 103:944-952.
30. Tsang C., Auger C., Mullen W., Bornet A., Rouanet J.-M., Crozier A., et al. The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Br J Nutr 2005, 94:170-181.
31. Donovan J.L., Manach C., Rios L., Morand C., Scalbert A., Remesy C. Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B-3. Br J Nutr 2002, 87:299-306.
32. Nakamura Y., Tonogai Y. Metabolism of grape seed polyphenol in the rat. J Agric Food Chem 2003, 51:7215-7225.
33. Wiese S., Esatbeyoglu T., Winterhalter P., Kruse H.P., Winkler S., Bub A., et al. Comparative biokinetics and metabolism of pure monomeric, dimeric and polymeric flavan-3-ols: a randomized cross-over study in humans. Mol Nutr Food Res 2014.
34. Wollgast J., Anklam E. Polyphenols in chocolate: is there a contribution to human health?. Food Res Int 2000, 33:449-459.
35. Boyer J., Liu R.H. Apple phytochemicals and their health benefits. Nutr J 2004, 3:5.
36. Gu Y., Hurst W.J., Stuart D.A., Lambert J.D. Inhibition of key digestive enzymes by cocoa extracts and procyanidins. J Agric Food Chem 2011, 59:5305-5311.
37. Holt R.R., Lazarus S.A., Sullards M.C., Zhu Q.Y., Schramm D.D., Hammerstone J.F., et al. Procyanidin dimer B2 epicatechin-(4 beta-8)-epicatechin in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr 2002, 76:798-804.
38. Donovan J.L., Crespy V., Oliveria M., Cooper K.A., Gibson B.B., Williamson G. (+)-Catechin is more bioavailable than (-)-catechin: relevance to the bioavailability of catechin from cocoa. Free Radic Res 2006, 40:1029-1034.
39. Deprez S., Mila I., Huneau J.F., Tome D., Scalbert A. Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial caco-2 cells. Antioxid Redox Sign 2001, 3:957-967.
40. Kosinska A., Andlauer W. Cocoa polyphenols are absorbed in caco-2 cell model of intestinal epithelium. Food Chem 2012, 135:999-1005.
41. Cardona F., Andres-Lacueva C., Tulipani S., Tinahones F.J., Queipo-Ortuno M.I. Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem 2013, 24:1415-1422.
42. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
43. Neilson A.P., George J.C., Janle E.M., Mattes R.D., Rudolph R., Matusheski N.V., et al. Influence of chocolate matrix composition on cocoa flavan-3-ol bioaccessibility in vitro and bioavailability in humans. J Agric Food Chem 2009, 57:9418-9426.
44. Baba S., Osakabe N., Yasuda A., Natsume M., Takizawa T., Nakamura T., et al. Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radic Res 2000, 33:635-641.
45. Roura E., Andres-Lacueva C., Estruch R., Mata-Bilbao M.L., Izquierdo-Pulido M., Waterhouse A.L., et al. Milk does not affect the bioavailability of cocoa powder flavonoid in healthy human. Ann Nutr Metab 2007, 51:493-498.
46. Williamson G. Possible effects of dietary polyphenols on sugar absorption and digestion. Mol Nutr Food Res 2013, 57:48-57.
47. Tzounis X., Vulevic J., Kuhnle G.G., George T., Leonczak J., Gibson G.R., et al. Flavanol monomer-induced changes to the human faecal microflora. Br J Nutr 2008, 99:782-792.
48. Selma M.V., Espin J.C., Tomas-Barberan F.A. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 2009, 57:6485-6501.
49. Goodrich K.M., Smithson A.T., Ickes A.K., Neilson A.P. Pan-colonic pharmacokinetics of catechins and procyanidins in male Sprague-Dawley rats. J Nutr Biochem 2015, 26:1007-1014.
50. Ou K., Sarnoski P., Schneider K.R., Song K., Khoo C., Gu L. Microbial catabolism of procyanidins by human gut microbiota. Mol Nutr Food Res 2014, 58:2196-2205.
51. Gonthier M.P., Donovan J.L., Texier O., Felgines C., Remesy C., Scalbert A. Metabolism of dietary procyanidins in rats. Free Radic Biol Med 2003, 35:837-844.
52. Larrosa M., Luceri C., Vivoli E., Pagliuca C., Lodovici M., Moneti G., et al. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Mol Nutr Food Res 2009, 53:1044-1054.
53. Wang D.J., Williams B.A., Ferruzzi M.G., D'Arcy B.R. Microbial metabolites, but not other phenolics derived from grape seed phenolic extract, are transported through differentiated caco-2 cell monolayers. Food Chem 2013, 138:1564-1573.
54. Gonthier M.-P., Cheynier V., Donovan J.L., Manach C., Morand C., Mila I., et al. Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J Nutr 2003, 133:461-467.
55. Forester S.C., Waterhouse A.L. Metabolites are key to understanding health effects of wine polyphenolics. J Nutr 2009, 139:1824S-1831S.
56. Williamson G., Clifford M.N. Colonic metabolites of berry polyphenols: the missing link to biological activity?. Br J Nutr 2010, 104:S48-S66.
57. Monagas M., Urpi-Sarda M., Sanchez-Patan F., Llorach R., Garrido I., Gomez-Cordoves C., et al. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct 2010, 1:233-253.
58. Fernández-Millán E., Ramos S., Alvarez C., Bravo L., Goya L., Martín M.Á. Microbial phenolic metabolites improve glucose-stimulated insulin secretion and protect pancreatic beta cells against tert-butyl hydroperoxide-induced toxicity via ERKs and PKC pathways. Food Chem Toxicol 2014, 66:245-253.
59. Carrasco-Pozo C., Gotteland M., Castillo R.L., Chen C. 3,4-dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, protects against pancreatic β-cells dysfunction induced by high cholesterol. Exp Cell Res 2015, 334:270-282.
60. Monagas Ma, Khan N., Andrés-Lacueva C., Urpí-Sard M., Vázquez-Agell Mn, Lamuela-Raventós RMa, et al. Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells. Br J Nutr 2009, 102:201-206.
61. Goodrich K.M., Neilson A.P. Simultaneous UPLC-MS/MS analysis of native catechins and procyanidins and their microbial metabolites in intestinal contents and tissues of male Wistar Furth inbred rats. J Chromatogr B 2014, 958:63-74.
62. Yamashita Y., Okabe M., Natsume M., Ashida H. Cacao liquor procyanidin extract improves glucose tolerance by enhancing GLUT4 translocation and glucose uptake in skeletal muscle. J Nutr Sci 2012, 1.
63. Gu Y., Yu S., Park J.Y., Harvatine K., Lambert J.D. Dietary cocoa reduces metabolic endotoxemia and adipose tissue inflammation in high-fat fed mice. J Nutr Biochem 2014, 25:439-445.
64. Yamashita Y., Okabe M., Natsume M., Ashida H. Cinnamtannin A2, a tetrameric procyanidin, increases GLP-1 and insulin secretion in mice. Biosci Biotech Bioch 2013, 77:888-891.
65. Matsumura Y., Nakagawa Y., Mikome K., Yamamoto H., Osakabe N. Enhancement of energy expenditure following a single oral dose of flavan-3-ols associated with an increase in catecholamine secretion. PLoS One 2014, 9.
66. Ruzaidi A., Amin I., Nawalyah A., Hamid M., Faizul H. The effect of malaysian cocoa extract on glucose levels and lipid profiles in diabetic rats. J Ethnopharmacol 2005, 98:55-60.
67. Tomaru M., Takano H., Osakabe N., Yasuda A., Inoue K., Yanagisawa R., et al. Dietary supplementation with cacao liquor proanthocyanidins prevents elevation of blood glucose levels in diabetic obese mice. Nutrition 2007, 23:351-355.
68. Jalil A.M.M., Ismail A., Chong P.P., Hamid M., Kamaruddin S.H.S. Effects of cocoa extract containing polyphenols and methylxanthines on biochemical parameters of obese-diabetic rats. J Sci Food Agric 2009, 89:130-137.
69. Yamashita Y. Prevention mechanisms of glucose intolerance and obesity by cacao liquor procyanidin extract in high-fat diet-fed C57BL/6 mice. Arch Biochem Biophys 2012, 527:95-104.
70. Watanabe N., Inagawa K., Shibata M., Osakabe N. Flavan-3-ol fraction from cocoa powder promotes mitochondrial biogenesis in skeletal muscle in mice. Lipids Health Dis 2014, 13:64.
71. Fernandez-Millan E., Cordero-Herrera I., Ramos S., Escriva F., Alvarez C., Goya L., et al. Cocoa-rich diet attenuates beta cell mass loss and function in young zucker diabetic fatty rats by preventing oxidative stress and beta cell apoptosis. Mol Nutr Food Res 2015.
72. Gutiérrez-Salmeán G., Jesús-Torres E.D., Ortiz-Vilchis P., Vacaseydel C., Garduño-Siciliano L., Meaney E., et al. Cardiometabolic alterations in Wistar rats induced by an obesogenic paigen-like diet: effects of (-) epicatechin. Diabetes Metab 2014, 5.
73. Si H., Fu Z., Babu P.V., Zhen W., Leroith T., Meaney M.P., et al. Dietary epicatechin promotes survival of obese diabetic mice and Drosophila melanogaster. J Nutr 2011, 141:1095-1100.
74. de Oliveira T.B., Genovese M.I. Chemical composition of cupuassu (Theobroma grandiflorum) and cocoa (Theobroma cacao) liquors and their effects on streptozotocin-induced diabetic rats. Food Res Int 2013, 51:929-935.
75. Gu Y., Yu S., Lambert J.D. Dietary cocoa ameliorates obesity-related inflammation in high fat-fed mice. Eur J Nutr 2014, 53:149-158.
76. Massot-Cladera M., Perez-Berezo T., Franch A., Castell M., Perez-Cano F.J. Cocoa modulatory effect on rat faecal microbiota and colonic crosstalk. Arch Biochem Biophys 2012, 527:105-112.
77. Brand-Miller J., Holt S.H., de Jong V., Petocz P. Cocoa powder increases postprandial insulinemia in lean young adults. J Nutr 2003, 133:3149-3152.
78. Grassi D., Lippi C., Necozione S., Desideri G., Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 2005, 81:611-614.
79. Grassi D., Necozione S., Lippi C., Croce G., Valeri L., Pasqualetti P., et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 2005, 46:398-405.
80. Grassi D., Desideri G., Necozione S., Lippi C., Casale R., Properzi G., et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr 2008, 138:1671-1676.
81. Haghighat N., Rostami A., Eghtesadi S., Shidfar F., Heidari I., Hoseini A. The effects of dark chocolate on glycemic control and blood pressure in hypertensive diabetic patients: a randomized clinical trial. Razi J Med Sci 2013, 20:78-86.
82. Almoosawi S., Fyfe L., Ho C., Al-Dujaili E. The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects. Br J Nutr 2010, 103:842-850.
83. Davison K., Coates A.M., Buckley J.D., Howe P.R. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes (Lond) 2008, 32:1289-1296.
84. Muniyappa R., Hall G., Kolodziej T.L., Karne R.J., Crandon S.K., Quon M.J. Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am J Clin Nutr 2008, 88:1685-1696.
85. Desideri G., Kwik-Uribe C., Grassi D., Necozione S., Ghiadoni L., Mastroiacovo D., et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the cocoa, cognition, and aging (CoCoA) study. Hypertension 2012, 60:794-801.
86. Stote K.S., Clevidence B.A., Novotny J.A., Henderson T., Radecki S.V., Baer D.J. Effect of cocoa and green tea on biomarkers of glucose regulation, oxidative stress, inflammation and hemostasis in obese adults at risk for insulin resistance. Eur J Clin Nutr 2012, 66:1153-1159.
87. Ramirez-Sanchez I., Taub P.R., Ciaraldi T.P., Nogueira L., Coe T., Perkins G., et al. (-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients. Int J Cardiol 2013, 168:3982-3990.
88. Basu A., Betts N.M., Leyva M.J., Fu D., Aston C.E., Lyons T.J. Acute cocoa supplementation increases postprandial HDL cholesterol and insulin in obese adults with type 2 diabetes after consumption of a high-fat breakfast. J Nutr 2015.
89. Mellor D.D., Sathyapalan T., Kilpatrick E.S., Beckett S., Atkin S.L. High-cocoa polyphenol-rich chocolate improves HDL cholesterol in type 2 diabetes patients. Diabet Med 2010, 27:1318-1321.
90. Stellingwerff T., Godin J.P., Chou C.J., Grathwohl D., Ross A.B., Cooper K.A., et al. The effect of acute dark chocolate consumption on carbohydrate metabolism and performance during rest and exercise. Applied physiology, nutrition, and metabolism = physiologie appliquee. Nutr Metab 2014, 39:173-182.
91. Goodrich K.M., Fundaro G., Griffin L.E., Grant A., Hulver M.W., Ponder M.A., et al. Chronic administration of dietary grape seed extract increases colonic expression of gut tight junction protein occludin and reduces fecal calprotectin in a secondary analysis of healthy Wistar Furth rats. Nutr Res 2012, 32:787-794.
92. Imai K., Tingley D., Yamamoto T. Experimental designs for identifying causal mechanisms. J R Stat Soc 2013, 176:5-51.
93. Casadevall A., Fang F.C. Descriptive science. Infect Immun 2008, 76:3835-3836.
94. Casadevall A., Fang F.C. Mechanistic science. Infect Immun 2009, 77:3517-3519.
95. Thompson H.J. Diet, nutrition, and cancer: development of hypotheses and their evaluation in animal studies. Cancer Res 1993, 53:2442s-2445s.
96. Fischman D. The 'descriptive' curse. The scientist 2003, LabX Media Group, Midland, Ontario, Canada.
97. Marincola F.M. In support of descriptive studies; relevance to translational research. J Transl Med 2007, 5:21.
98. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
99. Quesada I., Tuduri E., Ripoll C., Nadal A. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol 2008, 199:5-19.
100. Complications Due to Diabetes Diabetes. Centers for disease control and prevention 2014.
101. Hanhineva K., Torronen R., Bondia-Pons I., Pekkinen J., Kolehmainen M., Mykkanen H., et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010, 11:1365-1402.
102. Gu Y.Y., Hurst W.J., Stuart D.A., Lambert J.D. Inhibition of key digestive enzymes by cocoa extracts and procyanidins. J Agric Food Chem 2011, 59:5305-5311.
103. Yilmazer-Musa M., Griffith A.M., Michels A.J., Schneider E., Frei B. Grape seed and tea extracts and catechin 3-gallates are potent inhibitors of alpha-amylase and alpha-glucosidase activity. J Agric Food Chem 2012, 60:8924-8929.
104. Aydin S. A comparison of ghrelin, glucose, alpha-amylase and protein levels in saliva from diabetics. J Biochem Mol Biol 2007, 40:29-35.
105. Li Y., Wen S., Kota B.P., Peng G., Li G.Q., Yamahara J., et al. Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in zucker diabetic fatty rats. J Ethnopharmacol 2005, 99:239-244.
106. Barrett A., Ndou T., Hughey C.A., Straut C., Howell A., Dai Z., et al. Inhibition of alpha-amylase and glucoamylase by tannins extracted from cocoa, pomegranates, cranberries, and grapes. J Agric Food Chem 2013, 61:1477-1486.
107. Kwon O., Eck P., Chen S., Corpe C.P., Lee J.H., Kruhlak M., et al. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J 2007, 21:366-377.
108. Hossain S.J., Kato H., Aoshima H., Yokoyama T., Yamada M., Hara Y. Polyphenol-induced inhibition of the response of na(+)/glucose cotransporter expressed in xenopus oocytes. J Agric Food Chem 2002, 50:5215-5219.
109. D'Alessio D.A., Kahn S.E., Leusner C.R., Ensinck J.W. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest 1994, 93:2263.
110. Drucker D.J., Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006, 368:1696-1705.
111. Flint A., Raben A., Ersboll A.K., Holst J.J., Astrup A. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord 2001, 25:781-792.
112. Toft-Nielsen M.B., Damholt M.B., Madsbad S., Hilsted L.M., Hughes T.E., Michelsen B.K., et al. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocr Metab 2001, 86:3717-3723.
113. Weisburger J.H. Chemopreventive effects of cocoa polyphenols on chronic diseases. Exp Biol Med (Maywood) 2001, 226:891-897.
114. Horowitz M., Flint A., Jones K.L., Hindsberger C., Rasmussen M.F., Kapitza C., et al. Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes. Diabetes Res Clin Pr 2012, 97:258-266.
115. MacDonald P.E., El-Kholy W., Riedel M.J., Salapatek A.M., Light P.E., Wheeler M.B. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 2002, 51(Suppl. 3):S434-S442.
116. Gonzalez-Abuin N., Martínez-Micaelo N., Blay M., Ardévol A., Pinent M. Grape-seed procyanidins prevent the cafeteria-diet-induced decrease of glucagon-like peptide-1 production. J Agric Food Chem 2014, 62:1066-1072.
117. Gonzalez-Abuin N., Martinez-Micaelo N., Margalef M., Blay M., Arola-Arnal A., Muguerza B., et al. A grape seed extract increases active glucagon-like peptide-1 levels after an oral glucose load in rats. Food Funct 2014, 5:2357-2364.
118. Deacon C.F., Nauck M.A., Meier J., Hucking K., Holst J.J. Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocr Metab 2000, 85:3575-3581.
119. Aoki K., Masuda K., Miyazaki T., Togashi Y., Terauchi Y. Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men. Endocr J 2010, 57:667-672.
120. Gonzalez-Abuin N., Martinez-Micaelo N., Blay M., Pujadas G., Garcia-Vallve S., Pinent M., et al. Grape seed-derived procyanidins decrease dipeptidyl-peptidase 4 activity and expression. J Agric Food Chem 2012, 60:9055-9061.
121. Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 1999, 85:9-24.
122. Matteucci E., Giampietro O. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr Med Chem 2009, 16:2943-2951.
123. Pala L., Ciani S., Dicembrini I., Bardini G., Cresci B., Pezzatini A., et al. Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. Diabet Med 2010, 27:691-695.
124. Carr R.D., Larsen M.O., Jelic K., Lindgren O., Vikman J., Holst J.J., et al. Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. J Clin Endocr Metab 2010, 95:872-878.
125. Sudre B., Broqua P., White R.B., Ashworth D., Evans D.M., Haigh R., et al. Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats. Diabetes 2002, 51:1461-1469.
126. Craddy P., Palin H.-J., Johnson K.I. Comparative effectiveness of dipeptidylpeptidase-4 inhibitors in type 2 diabetes: a systematic review and mixed treatment comparison. Diabetes Ther 2014, 5:1-41.
127. Charbonnel B., Karasik A., Liu J., Wu M., Meininger G. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. Diabetes Care 2006, 29:2638-2643.
128. Muscelli E., Casolaro A., Gastaldelli A., Mari A., Seghieri G., Astiarraga B., et al. Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. J Clin Endocr Metab 2012, 97:2818-2826.
129. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
130. Tilg H., Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011, 121:2126-2132.
131. Anhe F.F., Roy D., Pilon G., Dudonne S., Matamoros S., Varin T.V., et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased akkermansia spp. population in the gut microbiota of mice. Gut 2014.
132. Cani P.D., Everard A. Akkermansia muciniphila: a novel target controlling obesity, type 2 diabetes and inflammation?. M S-Med Sci 2014, 30:125-127.
133. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995, 125:1401-1412.
134. Tzounis X., Rodriguez-Mateos A., Vulevic J., Gibson G.R., Kwik-Uribe C., Spencer J.P. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 2011, 93:62-72.
135. Gonzalez-Mariscal L., Betanzos A., Nava P., Jaramillo B.E. Tight junction proteins. Prog Biophys Mol Biol 2003, 81:1-44.
136. Suzuki T., Hara H. Role of flavonoids in intestinal tight junction regulation. J Nutr Biochem 2011, 22:401-408.
137. Beck I.T., Dinda P.K. Acute exposure of small intestine to ethanol: effects on morphology and function. Dig Dis Sci 1981, 26:817-838.
138. Brock-Utne J.G., Gaffin S.L., Wells M.T., Gathiram P., Sohar E., James M.F., et al. Endotoxaemia in exhausted runners after a long-distance race. SAMJ S Afr Med J 1988, 73:533-536.
139. Turner J.R. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009, 9:799-809.
140. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
141. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
142. Cani P.D. Metabolism in 2013: the gut microbiota manages host metabolism. Nat Rev Endocrinol 2014, 10:74-76.
143. Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., et al. Cross-talk between akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 2013, 110:9066-9071.
144. Song P., Zhang R., Wang X., He P., Tan L., Ma X. Dietary grape-seed procyanidins decreased postweaning diarrhea by modulating intestinal permeability and suppressing oxidative stress in rats. J Agric Food Chem 2011, 59:6227-6232.
145. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
146. Cani P.D., Geurts L., Matamoros S., Plovier H., Duparc T. Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond. Diabetes Metab 2014, 40:246-257.
147. Chassaing B., Gewirtz A.T. Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol Pathol 2014, 42:49-53.
148. Rodriguez-Ramiro I., Ramos S., Bravo L., Goya L., Martin M.A. Procyanidin B2 and a cocoa polyphenolic extract inhibit acrylamide-induced apoptosis in human caco-2 cells by preventing oxidative stress and activation of JNK pathway. J Nutr Biochem 2011, 22:1186-1194.
149. Hobson A., Draney C., Stratford A., Becker T.C., Lu D., Arlotto M., et al. Aurora kinase a is critical for the Nkx6.1 mediated β-cell proliferation pathway. Islets 2015, 7.
150. Martin M.A., Ramos S., Cordero-Herrero I., Bravo L., Goya L. Cocoa phenolic extract protects pancreatic beta cells against oxidative stress. Nutrients 2013, 5:2955-2968.
151. Youl E., Bardy G., Magous R., Cros G., Sejalon F., Virsolvy A., et al. Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Brit J Pharmacol 2010, 161:799-814.
152. Andres-Lacueva C., Monagas M., Khan N., Izquierdo-Pulido M., Urpi-Sarda M., Permanyer J., et al. Flavanol and flavonol contents of cocoa powder products: influence of the manufacturing process. J Agric Food Chem 2008, 56:3111-3117.
153. Coskun O., Kanter M., Korkmaz A., Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res 2005, 51:117-123.
154. Vessal M., Hemmati M., Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 2003, 135:357-364.
155. Ren W., Qiao Z., Wang H., Zhu L., Zhang L. Flavonoids: promising anticancer agents. Med Res Rev 2003, 23:519-534.
156. Baba S., Osakabe N., Kato Y., Natsume M., Yasuda A., Kido T., et al. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am J Clin Nutr 2007, 85:709-717.
157. Hii C.S.T., Howell S.L. Effects of flavonoids on insulin secretion and 45Ca2+ handling in rat islets of langerhans. J Endocrinol 1985, 107:1-8.
158. Jalil A.M., Ismail A., Pei C.P., Hamid M., Kamaruddin S.H. Effects of cocoa extract on glucometabolism, oxidative stress, and antioxidant enzymes in obese-diabetic (Ob-db) rats. J Agric Food Chem 2008, 56:7877-7884.
159. Pechhold K., Koczwara K., Zhu X., Harrison V.S., Walker G., Lee J., et al. Blood glucose levels regulate pancreatic β-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice. PLoS One 2009, 4.
160. Hii C., Brown D., Smith W., Howell S. Assessment of the antidiabetic activity of epicatechin in streptozotocin-diabetic and spontaneously diabetic BB/E rats. Biosci Rep 1985, 5:215-221.
161. Chakravarthy B., Gupta S., Gambhir S., Gode K. Pancreatic beta-cell regeneration in rats by (-)-epicatechin. Lancet 1981, 318:759-760.
162. Chakravarthy B.K., Gupta S., Gambhir S.S., Gode K.D. The prophylactic action of (-)-epicatechin against alloxan induced diabetes in rats. Life Sci 1981, 29:2043-2047.
163. Fu Z., Yuskavage J., Liu D. Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice. J Agric Food Chem 2013, 61:4303-4309.
164. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
165. Cordero-Herrera I., Martin M.A., Bravo L., Goya L., Ramos S. Cocoa flavonoids improve insulin signalling and modulate glucose production via AKT and AMPK in HepG2 cells. Mol Nutr Food Res 2013, 57:974-985.
166. Cordero-Herrera I., Martín M.Á., Goya L., Ramos S. Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells. Food Chem Toxicol 2014, 64:10-19.
167. Kahn B.B., Rosen A.S., Bak J.F., Andersen P.H., Damsbo P., Lund S., et al. Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors. J Clin Endocr Metab 1992, 74:1101-1109.
168. Min S.Y., Yang H., Seo S.G., Shin S.H., Chung M.Y., Kim J., et al. Cocoa polyphenols suppress adipogenesis in vitro and obesity in vivo by targeting insulin receptor. Int J Obes (Lond) 2013, 37:584-592.
169. Hooper L., Kroon P.A., Rimm E.B., Cohn J.S., Harvey I., Le Cornu K.A., et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008, 88:38-50.
170. Wan Y., Vinson J.A., Etherton T.D., Proch J., Lazarus S.A., Kris-Etherton P.M. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 2001, 74:596-602.
171. Taubert D., Roesen R., Lehmann C., Jung N., Schomig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 2007, 298:49-60.
172. Fraga C.G., Actis-Goretta L., Ottaviani J.I., Carrasquedo F., Lotito S.B., Lazarus S., et al. Regular consumption of a flavanol-rich chocolate can improve oxidant stress in young soccer players. Clin Dev Immunol 2005, 12:11-17.
173. Balzer J., Rassaf T., Heiss C., Kleinbongard P., Lauer T., Merx M., et al. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol 2008, 51:2141-2149.
174. Jia L., Liu X., Bai Y.Y., Li S.H., Sun K., He C., et al. Short-term effect of cocoa product consumption on lipid profile: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2010, 92:218-225.
175. Sugiyama H., Akazome Y., Shoji T., Yamaguchi A., Yasue M., Kanda T., et al. Oligomeric procyanidins in apple polyphenol are main active components for inhibition of pancreatic lipase and triglyceride absorption. J Agric Food Chem 2007, 55:4604-4609.
176. Janevski M., Antonas K.N., Sullivan-Gunn M.J., McGlynn M.A., Lewandowski P.A. The effect of cocoa supplementation on hepatic steatosis, reactive oxygen species and LFABP in a rat model of NASH. Comp Hepatol 2011, 10:1-13.
177. Castell-Auvi A., Cedo L., Pallares V., Blay M., Pinent M., Ardevol A. Grape seed procyanidins improve beta-cell functionality under lipotoxic conditions due to their lipid-lowering effect. J Nutr Biochem 2013, 24:948-953.
178. Eckardt K., Taube A., Eckel J. Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. Rev Endrocr Metab Dis 2011, 12:163-172.
179. Martins A.R., Nachbar R.T., Gorjao R., Vinolo M.A., Festuccia W.T., Lambertucci R.H., et al. Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function. Lipids Health Dis 2012, 11:1-11.
180. Turner N., Kowalski G., Leslie S., Risis S., Yang C., Lee-Young R., et al. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 2013, 56:1638-1648.
181. Cordero-Herrera I., Martín M.Á., Escrivá F., Álvarez C., Goya L., Ramos S. Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in zucker diabetic fatty rats. J Nutr Biochem 2015.
182. Martín M.Á., Fernández-Millán E., Ramos S., Bravo L., Goya L. Cocoa flavonoid epicatechin protects pancreatic beta cell viability and function against oxidative stress. Mol Nutr Food Res 2013, 1-10.
183. Davidson M.H., Hauptman J., DiGirolamo M., Foreyt J.P., Halsted C.H., Heber D., et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 1999, 281:235-242.
184. Torgerson J.S., Hauptman J., Boldrin M.N., Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004, 27:155-161.
185. Heymsfield S.B., Segal K.R., Hauptman J., et al. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000, 160:1321-1326.
186. Ali F., Ismail A., Esa N.M., Pei C. Cocoa polyphenols treatment ameliorates visceral obesity by reduction lipogenesis and promoting fatty acid oxidation genes in obese rats through interfering with AMPK pathway. Eur J Lipid Sci Tech 2015, [n/a-n/a.].
187. Ali F., Ismail A., Esa N.M., Pei C.P. Transcriptomics expression analysis to unveil the molecular mechanisms underlying the cocoa polyphenol treatment in diet-induced obesity rats. Genomics 2015, 105:23-30.
188. Ali F., Ismail A., Esa N.M., Pei C.P., Kersten S. Hepatic genome-wide expression of lipid metabolism in diet-induced obesity rats treated with cocoa polyphenols. J Funct Foods 2015, 17:969-978.
189. Ali F., Ismail A., Kersten S. Molecular mechanisms underlying the potential antiobesity-related diseases effect of cocoa polyphenols. Mol Nutr Food Res 2014, 58:33-48.
190. Gutierrez-Salmean G., Ortiz-Vilchis P., Vacaseydel C.M., Garduno-Siciliano L., Chamorro-Cevallos G., Meaney E., et al. Effects of (-)-epicatechin on a diet-induced rat model of cardiometabolic risk factors. Eur J Pharmacol 2014, 728:24-30.
191. Bergman M. Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine 2013, 43:504-513.
192. Wang J.-S., Lin S.-D., Lee W.-J., Su S.-L., Lee I.T., Tu S.-T., et al. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison. Clin Ther 2011, 33:1932-1942.
193. Li C., Hung Y.-J., Qamruddin K., Aziz M.F.A., Stein H., Schmidt B. International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pr 2011, 92:57-64.
194. Nauck M.A. A critical analysis of the clinical use of incretin-based therapies: the benefits by far outweigh the potential risks. Diabetes Care 2013, 36:2126-2132.
195. Karagiannis T., Paschos P., Paletas K., Matthews D.R., Tsapas A. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis 2012.
196. Saukkonen T., Cederberg H., Jokelainen J., Laakso M., Härkönen P., Keinänen-Kiukaanniemi S., et al. Limited overlap between intermediate hyperglycemia as defined by A1C 5.7-6.4%, impaired fasting glucose, and impaired glucose tolerance. Diabetes Care 2011, 34:2314-2316.
197. Rathmann W., Kowall B., Tamayo T., Giani G., Holle R., Thorand B., et al. Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 study. Ann Med 2012, 44:170-177.
198. Oda E. Comparison between prediabetes defined by hemoglobin A1c (A1C) 5.7-6.4% and that defined by impaired fasting glucose (IFG) in a Japanese population. J Diabetes Metab 2011.
199. Rein M.J., Renouf M., Cruz-Hernandez C., Actis-Goretta L., Thakkar S.K., da Silva Pinto M. Bioavailability of bioactive food compounds: a challenging journey to bioefficacy. Br J Clin Pharmacol 2013, 75:588-602.
200. Lewandowska U., Szewczyk K., Hrabec E., Janecka A., Gorlach S. Overview of metabolism and bioavailability enhancement of polyphenols. J Agric Food Chem 2013, 61:12183-12199.
201. Rubio L., Macia A., Motilva M.-J. Impact of various factors on pharmacokinetics of bioactive polyphenols: an overview. Curr Drug Metab 2014, 15:62-76.
202. Appeldoorn M.M., Vincken J.P., Gruppen H., Hollman P.C.H. Procyanidin dimers A1, A2, and B2 are absorbed without conjugation or methylation from the small intestine of rats. J Nutr 2009, 139:1469-1473.
203. Sano A., Yamakoshi J., Tokutake S., Tobe K., Kubota Y., Kikuchi M. Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract. Biosci Biotech Bioch 2003, 67:1140-1143.
204. Stoupi S., Williamson G., Viton F., Barron D., King L.J., Brown J.E., et al. In vivo bioavailability, absorption, excretion, and pharmacokinetics of [14C]procyanidin B2 in male rats. Drug Metab Dispos 2010, 38:287-291.
205. Ottaviani J.I., Kwik-Uribe C., Keen C.L., Schroeter H. Intake of dietary procyanidins does not contribute to the pool of circulating flavanols in humans. Am J Clin Nutr 2012, 95:851-858.
206. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81:230S-242S.
207. Crozier A., Del Rio D., Clifford M.N. Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 2010, 31:446-467.
208. Prasain J.K., Peng N., Dai Y.Y., Moore R., Arabshahi A., Wilson L., et al. Liquid chromatography tandem mass spectrometry identification of proanthocyanidins in rat plasma after oral administration of grape seed extract. Phytomedicine 2009, 16:233-243.
209. Mudie D.M., Murray K., Hoad C.L., Pritchard S.E., Garnett M.C., Amidon G.L., et al. Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. Mol Pharm 2014, 11:3039-3047.
210. Sapwarobol S., Adisakwattana S., Changpeng S., Ratanawachirin W., Tanruttanawong K., Boonyarit W. Postprandial blood glucose response to grape seed extract in healthy participants: a pilot study. Pharmacog Mag 2012, 8:192-196.
211. Cvitkusic S. Glycemic response to muscadine grape components, comparing healthy weight and overweight individuals. FASEB J 2012, 26:636.10.
212. Edirisinghe I., Randolph J., Cheema M., Tadapaneni R., Park E., Burton-Freeman B., et al. Effect of grape seed extract on postprandial oxidative status and metabolic responses in men and women with the metabolic syndrome - randomized, cross-over, placebo-controlled study. Funct Foods Health Dis 2012, 2:508-521.
213. Hussain S.A., Sulaiman A.A., Aljamaly A.A., Abdulrahman R. Effect of proanthocyanidin single oral dose on glucose tolerance in response oral maltose load in healthy women. J Intercult Ethnopharmacol 2013, 2:43-48.
214. Gutierrez-Salmean G., Ortiz-Vilchis P., Vacaseydel C.M., Rubio-Gayosso I., Meaney E., Villarreal F., et al. Acute effects of an oral supplement of (-)-epicatechin on postprandial fat and carbohydrate metabolism in normal and overweight subjects. Food Funct 2014, 5:521-527.
215. Gu Y., Yu S., Park J.Y., Harvatine K., Lambert J.D. Dietary cocoa reduces metabolic endotoxemia and adipose tissue inflammation in high-fat fed mice. J Nutr Biochem 2013, 439-45.
216. Banini A.E., Boyd L.C., Allen J.C., Allen H.G., Sauls D.L. Muscadine grape products intake, diet and blood constituents of non-diabetic and type 2 diabetic subjects. Nutrition 2006, 22:1137-1145.
217. Hosoda K., Wang M.-F., Liao M.-L., Chuang C.-K., Iha M., Clevidence B., et al. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 2003, 26:1714-1718.
218. Sivaprakasapillai B., Edirisinghe I., Randolph J., Steinberg F., Kappagoda T. Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metab Clin Exp 2009, 58:1743-1746.
219. Kar P., Laight D., Rooprai H.K., Shaw K.M., Cummings M. Effects of grape seed extract in type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity. Diabet Med 2009, 26:526-531.
220. Osakabe N., Baba S., Yasuda A., Iwamoto T., Kamiyama M., Takizawa T., et al. Daily cocoa intake reduces the susceptibility of low-density lipoprotein to oxidation as demonstrated in healthy human volunteers. Free Radic Res 2001, 34:93-99.
221. Almstrup K., Fernández M.F., Petersen J.H., Olea N., Skakkebaek N.E., Leffers H. Dual effects of phytoestrogens result in u-shaped dose-response curves. Environ Health Persp 2002, 110:743-748.
222. Grundmann O., Wang J., McGregor G.P., Butterweck V. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta Med 2008, 74:1769-1773.
223. Calabrese E.J., Baldwin L.A. HORMESIS: the dose-response revolution. Annu Rev Pharmacol 2003, 43:175-197.
224. Chirumbolo S. Hormesis, resveratrol and plant-derived polyphenols: some comments. Hum Exp Toxicol 2011, 30:2027-2030.
225. Matsui N., Ito R., Nishimura E., Yoshikawa M., Kato M., Kamei M., et al. Ingested cocoa can prevent high-fat diet-induced obesity by regulating the expression of genes for fatty acid metabolism. Nutrition 2005, 21:594-601.
226. Pérez-Berezo T., Franch A., Ramos-Romero S., Castellote C., Pérez-Cano F.J., Castell M. Cocoa-enriched diets modulate intestinal and systemic humoral immune response in young adult rats. Mol Nutr Food Res 2011, 55:S56-S66.
227. Papadimitriou A., Peixoto E.B., Silva K.C. Lopes de faria JM, lopes de faria JB. Increase in AMPK brought about by cocoa is renoprotective in experimental diabetes mellitus by reducing NOX4/TGFbeta-1 signaling. J Nutr Biochem 2014, 25:773-784.
228. Ruzaidi A.M.M., Abbe M.M.J., Amin I., Nawalyahl A.G., Muhajirl H. Protective effect of polyphenol-rich extract prepared from malaysian cocoa (Theobroma cacao) on glucose levels and lipid profiles in streptozotocin-induced diabetic rats. J Sci Food Agric 2008, 88:1442-1447.
229. Jalil A.M.M., Ismail A., Pei C.P., Hamid M., Kamaruddin S.H.S. Effects of cocoa extract on glucometabolism, oxidative stress, and antioxidant enzymes in obese-diabetic (Ob-db) rats. J Agric Food Chem 2008, 56:7877-7884.
230. Baba S., Osakabe N., Natsume M., Muto Y., Takizawa T., Terao J. Absorption and urinary excretion of (-)-epicatechin after administration of different levels of cocoa powder or (-)-epicatechin in rats. J Agric Food Chem 2001, 49:6050-6056.
231. Yamashita Y., Okabe M., Natsume M., Ashida H. Comparison of anti-hyperglycemic activities between low- and high-degree of polymerization procyanidin fractions from cacao liquor extract. J Food Drug Anal 2012, 20:283-287.
232. Radziuk J. Homeostastic model assessment and insulin sensitivity/resistance. Diabetes 2014, 63:1850-1854.
233. Anderson A.S., Haynie K.R., McMillan R.P., Osterberg K.L., Boutagy N.E., Frisard M.I., et al. Early skeletal muscle adaptations to short-term high-fat diet in humans before changes in insulin sensitivity. Obesity 2015, 23:720-724.
234. Bell J.A., Reed M.A., Consitt L.A., Martin O.J., Haynie K.R., Hulver M.W., et al. Lipid partitioning, incomplete fatty acid oxidation, and insulin signal transduction in primary human muscle cells: effects of severe obesity, fatty acid incubation, and fatty acid translocase/CD36 overexpression. J Clin Endocr Metab 2010, 95:3400-3410.
235. Boutagy N.E., Marinik E.L., McMillan R.P., Anderson A.S., Frisard M.I., Davy B.M., et al. Angiotensin II receptor blockade and skeletal muscle metabolism in overweight and obese adults with elevated blood pressure. Ther Adv Cardiovasc Dis 2015, 9:45-50.
236. Frisard M.I., McMillan R.P., Marchand J., Wahlberg K.A., Wu Y., Voelker K.A., et al. Toll-like receptor 4 modulates skeletal muscle substrate metabolism. Am J Physiol Endocrinol Metab 2010, 298:E988-E98.
237. Frisard M.I., Wu Y., McMillan R.P., Voelker K.A., Wahlberg K.A., Anderson A.S., et al. Low levels of lipopolysaccharide modulate mitochondrial oxygen consumption in skeletal muscle. Metabolis 2015, 64:416-427.
238. Hulver M.W., Berggren J.R., Carper M.J., Miyazaki M., Ntambi J.M., Hoffman E.P., et al. Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab 2005, 2:251-261.
239. Hulver M.W., Berggren J.R., Cortright R.N., Dudek R.W., Thompson R.P., Pories W.J., et al. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 2003, 284:E741-E747.
240. McMillan R.P., Wu Y., Voelker K., Fundaro G., Kavanaugh J., Stevens J.R., et al. Selective overexpression of toll-like receptor-4 in skeletal muscle impairs metabolic adaptation to high-fat feeding. Am J Physiol-Reg I 2015, 309:R304-R13.
241. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008, 22:659-661.
242. Perez-Berezo T., Franch A., Ramos-Romero S., Castellote C., Perez-Cano F.J., Castell M. Cocoa-enriched diets modulate intestinal and systemic humoral immune response in young adult rats. Mol Nutr Food Res 2011, 55(Suppl. 1):S56-S66.
243. Yamashita Y., Okabe M., Natsume M., Ashida H. Prevention mechanisms of glucose intolerance and obesity by cacao liquor procyanidin extract in high-fat diet-fed C57BL/6 mice. Arch Biochem Biophys 2012, 527:95-104.
244. Nguyen N.U., Henriet M.T., Dumoulin G., Widmer A., Regnard J. Increase in calciuria and oxaluria after a single chocolate bar load. Horm Metab Res 1994, 26:383-386.